A new stem cell therapy for Parkinson’s disease is one step closer to human trials after scientists were able to successfully rebuild neural damage in an animal model.
Researchers from Scripps Research and Cardiff University used induced pluripotent stem cells (iPSCs) from skin cells of two people with Parkinson’s disease to grow young neurons, which were then transplanted into rats with the degenerative condition. By timing the growth of the new cells just right, they’re able to replace the damaged neurons and potentially reverse the physical impairments that come with the neural damage.
